During a one-year period (1985) 40 consecutive infertile patients for which mild endometriosis was diagnosed by laparoscopy were treated with gestrinone (Roussel-Uclaf, Paris, France), 2.5 mg twice a week, during 4 months. All these patients had infertility of long duration (57 months). Infertility could not be sufficiently explained in view of the results of the basic work-up, either that this basic work-up was totally normal, or that anomalies exhibited were not sharp enough to be the only probable reason for the infertile condition.
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Gestrinone therapy was well tolerated in the majority of the cases. The main discomfort was due to frequent bleeding (24%). Four spontaneous pregnancies were obtained with a main delay between the end of therapy and the beginning of pregnancy of 8 months. Two more pregnancies were obtained by in vitro fertilization (13 cycles, 11 patients, 2 pregnancies).
Conclusions are that gestrinone is a well-tolerated therapy, but its efficacy on endometrial implants and on subsequent infertility associated with endometriosis remains to be confirmed. On the other hand, since estrogens are diminished, sex hormone binding globulin (SHBG) secretion at hepatic levels could also be impaired, thus resulting in increased levels of free androgens.
All this could result in the existence of a predominantly androgenic hormonal profile in the women treated with this substance. To study this aspect, 12 normally cycling women, being treated for endometriosis with buserelin (HOE 766) at doses of 300 pg every 8 h intranasally, for 6 months, have been considered. Basal, 15-day and afterwards monthly serum samples were taken and kept frozen until the end of the study.
Luteinizing hormone (LH), estradiol testosterone and SHBG were determined by radioimmunoassay and a free testosterone index (FTI) has been calculated. FTI = (T/SHBG) X 100.
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A variance analysis has shown a significant decrease in estradiol levels, while testosterone, LH, SHBG, and FTI levels did not experience any significant change.
According to these findings it can be concluded that the chronic ovarian suppression with buserelin did not influence negatively the androgenic profile. Among 214 punctured cysts, 62% contained between 10 and 400 ml (27-91 mm diameter).
Judged by 79 surgical controls, the reliability of cytology is 84%: it eliminated corpus luteum cysts, revealed among 214 ovarian endometriosis almost 50% of intra-ovarian hidden cases, and contributed to the discovery of 3 endometriotic malign cysts of benign aspect ( 1 false-negative).
Among 186 patients, 24 had complementary surgical cyst resections. 139 patients bearing 155 cysts were followed-up after puncture: 80% for more than 2 years, 50% between 6 and 20 years. Most of the prescriptions (33 different gynecologists) were not correctly followed.
Among 109 second-looks and/or ultrasonic controls: 47 cases of persistance or recurrence, 62 showed no cysts, although 15 had revealed cysts from 50 to 100 ml.
Among 65 patients who wanted children, 31 bore 40 known living children, although 16 had had large punctured cysts of 50-400 ml.
Conclusions
This technique seems appropriate to young, nulliparous or sterile women, and should be used before long prescriptions and before surgical resections which do not always prevent recurrence and may cause adhesions. Fifteen patients were treated with 400 mg/day and another 15 patients with 300 mg/day of danol. Blood samples were taken before the treatment and in monthly intervals thereafter. Serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin, hydroxycortisone, estradiol and progesterone levels were determined with radioimmunoassays.
